Related Experiment Video
Updated: Aug 13, 2026

RhoC GTPase Activation Assay
Published on: August 23, 2010
Androgen receptor activation by G(s) signaling in prostate cancer cells
Elizabeth A Kasbohm1, Rishu Guo, Charles W Yowell
1Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
The androgen receptor (AR) is activated in prostate cancer patients undergoing androgen ablative therapy and mediates growth of androgen-insensitive prostate cancer cells, suggesting it is activated by nonandrogenic factors. We demonstrate that activated alpha subunit of heterotrimeric guanine nucleotide-binding G(s) protein activates the AR in prostate cancer cells and also synergizes with low concentration of androgen to more fully activate the AR. The G alpha(s) activates protein kinase A, which is required for the nuclear partition and activation of AR. These data suggest a role for G alpha(s) and PKA in the transactivation of AR in prostate cancer cells under the environment of reduced androgen levels.
Insights
Activated G(s) protein and protein kinase A (PKA) activate the androgen receptor (AR) in prostate cancer cells, even with low androgen levels. This finding offers new insights into prostate cancer growth mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Androgen receptor (AR) activation is crucial in prostate cancer progression.
- AR remains active in androgen-insensitive prostate cancer, suggesting nonandrogenic activation pathways.
- Androgen ablative therapy aims to reduce AR signaling but can lead to resistance.
Purpose of the Study:
- To investigate the role of nonandrogenic factors in activating the androgen receptor (AR) in prostate cancer cells.
- To determine if the G(s) protein alpha subunit (G alpha(s)) influences AR activity.
- To elucidate the signaling pathway linking G alpha(s) to AR activation.
Main Methods:
- Utilized prostate cancer cell models.
- Assessed the effect of activated G alpha(s) on AR activity.
- Investigated the role of protein kinase A (PKA) in AR nuclear translocation and activation.
- Examined the synergistic effect of G alpha(s) and low androgen concentrations on AR.
Main Results:
- Activated G alpha(s) was found to activate the androgen receptor (AR) in prostate cancer cells.
- G alpha(s) synergizes with low androgen concentrations to enhance AR activation.
- G alpha(s) activates protein kinase A (PKA), which is essential for AR nuclear localization and subsequent activation.
- These findings highlight a novel pathway for AR transactivation.
Conclusions:
- The G alpha(s) protein and its downstream effector PKA play a significant role in androgen receptor (AR) transactivation.
- This pathway is particularly relevant in prostate cancer cells experiencing reduced androgen levels.
- Targeting the G alpha(s)-PKA pathway could offer new therapeutic strategies for advanced prostate cancer.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
G-protein Coupled Receptors
The Ras Gene
Ras is a superfamily...
Amplifying Signals via Enzymatic Cascade
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity
Two...